Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical Inc (NQ: NARI )

65.47 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 65.47
Bid (Size) 64.15 (1)
Ask (Size) 71.00 (1)
Prev. Close 65.47
Today's Range 65.47 - 65.47
52wk Range 52.59 - 83.84
Shares Outstanding 54,313,676
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Inari Medical to Present at Upcoming Investor Conferences
From Inari Medical, Inc.
Via GlobeNewswire
2 Top Healthcare Stocks I'd Buy Now Without Hesitation
Whether you're seeking dividends or explosive growth, the economy's most reliable sector has something for you. 
Via The Motley Fool

Performance

YTD
+7.79%
+7.79%
1 Month
-0.55%
-0.55%
3 Month
+13.00%
+13.00%
6 Month
+6.09%
+6.09%
1 Year
-3.09%
-3.09%

More News

Read More
Inari Medical Stock Gained 21% on Thursday - Here's Why It Soared
Via Benzinga
Why Shares of Inari Medical Are Up Thursday
Via The Motley Fool
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Looking Into Inari Medical's Return On Invested Capital
Via Benzinga
Inari Medical Reports Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the 43rd Annual Canaccord Growth Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce Second Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous Thromboembolism
From Inari Medical, Inc.
Via GlobeNewswire
Analyst Expectations for Inari Medical's Future
Via Benzinga
Inari Medical: Q1 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
Via Benzinga
Inari Medical Announces the Release of 2022 Ethos and Sustainability Report
From Inari Medical, Inc.
Via GlobeNewswire
Why Shares of Inari Medical Rose This Week
Via The Motley Fool
Inari Medical Earnings Preview
Via Benzinga
Analyst Ratings for Inari Medical
Via Benzinga
Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports First Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Present at the Bank of America 2023 Healthcare Conference
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical to Announce First Quarter 2023 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System
From Inari Medical, Inc.
Via GlobeNewswire
Inari Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Inari Medical, Inc.
Via GlobeNewswire
Earnings Scheduled For February 27, 2023
Via Benzinga
3 Magnificent Growth Stocks With 38% to 64% Upside Potential, According to Wall Street
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.